Mesoblast quarterly loss
Mesoblast recorded a loss of $US22.84 million for the September quarter or US3.49¢ a share, from $US24.06 million in the same period a year ago, or US4.21¢ a share. Revenue was $US3.59 million from $US1.31 million.
Cash on hand at the end of the quarter was $US115.96 million, pre-dating a $US90 million financing deal with Oaktree struck in November. The board and management believe the company can sustain the next 12 months of operations. Beyond that, Mesoblast still has $US40 million of finance available to it contingent upon reaching certain hurdles or strategic deals.
"However, whether the group can achieve its objectives for extending the cash runway beyond the 12 month period creates material uncertainty which may cast significant doubt... on our ability to continue as a going concern," the company said.
Mesoblast quarterly loss Mesoblast recorded a loss of $US22.84...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.003(0.24%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.08 | $1.04 | $2.991M | 2.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 88030 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 43198 | 9 |
View Market Depth
| Last trade - 12.31pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.05 |
Change
0.003 ( 0.43 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.08 | $1.04 | 316686 | ||
| Last updated 12.50pm 11/06/2024 ? | |||||
| MSB (ASX) Chart |